Jefferies Group’s AdaptHealth AHCO Stock Holding History

Jefferies Group’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-66,500	Closed	-$2.44M	–	1629
2021 Q1	$2.44M	Buy	+66,500	New	+$2.35M	0.02%	607

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's AHCO Position: Q1 2020 in Review

Jefferies Group sold out of AdaptHealth (AHCO) in Q1 2020, closing a stake of 10,000 shares — an estimated $110K sold.

Jefferies Group first reported a position in AHCO in Q4 2019 and held it in 1 quarter. The position peaked at $110K in Q4 2019. 35 funds tracked by Wall St. Rank hold AHCO as of Q1 2020.

Jefferies Group reported no remaining AdaptHealth position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 10,000 AdaptHealth shares in Q1 2020, an estimated $110K.
Jefferies Group first reported a position in AdaptHealth in Q4 2019 and held it in 1 quarter.
Jefferies Group's AdaptHealth position peaked at $110K in Q4 2019.
35 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.